248 related articles for article (PubMed ID: 36819577)
1. Identification of novel key genes associated with uterine corpus endometrial carcinoma progression and prognosis.
Li H; Zhou Q; Wu Z; Lu X
Ann Transl Med; 2023 Jan; 11(2):100. PubMed ID: 36819577
[TBL] [Abstract][Full Text] [Related]
2. Identification of Hub Genes Correlated With Poor Prognosis for Patients With Uterine Corpus Endometrial Carcinoma by Integrated Bioinformatics Analysis and Experimental Validation.
Yuan Y; Chen Z; Cai X; He S; Li D; Zhao W
Front Oncol; 2021; 11():766947. PubMed ID: 34868993
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis of RNA sequencing data reveals multiple key genes in uterine corpus endometrial carcinoma.
Shen L; Liu M; Liu W; Cui J; Li C
Oncol Lett; 2018 Jan; 15(1):205-212. PubMed ID: 29387216
[TBL] [Abstract][Full Text] [Related]
4. [Dysregulation of MAD2L1/CAMK2A/PTTG1 Gene Cluster Maintains the Stemness Characteristics of Uterine Corpus Endometrial Carcinoma].
Zheng J; Zhang YW; Pan ZF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Oct; 43(5):685-695. PubMed ID: 34728029
[TBL] [Abstract][Full Text] [Related]
5. Exploring Prognosis-Associated Biomarkers of Estrogen-Independent Uterine Corpus Endometrial Carcinoma by Bioinformatics Analysis.
Ye Y; Li H; Bian J; Wang L; Wang Y; Huang H
Int J Gen Med; 2021; 14():9067-9081. PubMed ID: 34876842
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive bioinformatic analyses of lncRNA-mediated ceRNA network for uterine corpus endometrial carcinoma.
Cai Y; Cui J; Wang Z; Wu H
Transl Cancer Res; 2022 Jul; 11(7):1994-2012. PubMed ID: 35966302
[TBL] [Abstract][Full Text] [Related]
7. KDM4B, a potential prognostic biomarker revealed by large-scale public databases and clinical samples in uterine corpus endometrial carcinoma.
Zhang M; Liu Y; Hou S; Wang Y; Wang C; Yin Y; Chen X
Mol Omics; 2022 Jul; 18(6):506-519. PubMed ID: 35485290
[TBL] [Abstract][Full Text] [Related]
8. Identification of a Four-Gene Signature With Prognostic Significance in Endometrial Cancer Using Weighted-Gene Correlation Network Analysis.
Huang S; Pang L; Wei C
Front Genet; 2021; 12():678780. PubMed ID: 34616422
[TBL] [Abstract][Full Text] [Related]
9. ASPM, CDC20, DLGAP5, BUB1B, CDCA8, and NCAPG May Serve as Diagnostic and Prognostic Biomarkers in Endometrial Carcinoma.
Zhang Q; Wang Y; Xue F
Genet Res (Camb); 2022; 2022():3217248. PubMed ID: 36186000
[TBL] [Abstract][Full Text] [Related]
10. KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma.
He K; Li J; Huang X; Zhao W; Wang K; Wang T; Chen J; Wang Z; Yi J; Zhao S; Zhao L
Front Oncol; 2023; 13():1090779. PubMed ID: 36776306
[TBL] [Abstract][Full Text] [Related]
11. LHX1 as a potential biomarker regulates EMT induction and cellular behaviors in uterine corpus endometrial carcinoma.
Tian Y; Wen F; Wang S; Lv N
Clinics (Sao Paulo); 2022; 77():100103. PubMed ID: 36116266
[TBL] [Abstract][Full Text] [Related]
12. The Expression of Pyroptosis-Related Gene May Influence the Occurrence, Development, and Prognosis of Uterine Corpus Endometrial Carcinoma.
Huang X; Li Y; Li J; Yang X; Xiao J; Xu F
Front Oncol; 2022; 12():885114. PubMed ID: 35574367
[TBL] [Abstract][Full Text] [Related]
13. Elevated Expression of Gamma-Glutamyl Hydrolase Is Associated With Poor Prognosis and Altered Immune Signature in Uterine Corpus Endometrial Carcinoma.
Yu C; Qi H; Zhang Y; Zhao W; Wu G
Front Genet; 2021; 12():764194. PubMed ID: 35082830
[TBL] [Abstract][Full Text] [Related]
14. Immune-related gene
Nong B; Su T; Jin M; Huang J; Huang A; Fang D; Wei J
Transl Cancer Res; 2021 Jun; 10(6):2962-2976. PubMed ID: 35116604
[TBL] [Abstract][Full Text] [Related]
15. Construction of Oxidative Stress-Related Genes Risk Model Predicts the Prognosis of Uterine Corpus Endometrial Cancer Patients.
Liu Q; Yu M; Zhang T
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428665
[TBL] [Abstract][Full Text] [Related]
16. Identification of a five-gene signature for predicting the progression and prognosis of stage I endometrial carcinoma.
Bian J; Xu Y; Wu F; Pan Q; Liu Y
Oncol Lett; 2020 Sep; 20(3):2396-2410. PubMed ID: 32782557
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of oxeiptosis-associated lncRNAs and prognosis-related signature genes to predict the immune status in uterine corpus endometrial carcinoma.
Niu L; Wu Z
Aging (Albany NY); 2023 May; 15(10):4236-4252. PubMed ID: 37211398
[TBL] [Abstract][Full Text] [Related]
18. miR-149-3p Is a Potential Prognosis Biomarker and Correlated with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma.
Lu X; Jing L; Liu S; Wang H; Chen B
Int J Endocrinol; 2022; 2022():5006123. PubMed ID: 35719192
[TBL] [Abstract][Full Text] [Related]
19. Construction and verification of an endoplasmic reticulum stress-related prognostic model for endometrial cancer based on WGCNA and machine learning algorithms.
Lin S; Wei C; Wei Y; Fan J
Front Oncol; 2024; 14():1362891. PubMed ID: 38725627
[TBL] [Abstract][Full Text] [Related]
20. Upregulated ENC1 predicts unfavorable prognosis and correlates with immune infiltration in endometrial cancer.
He L; He W; Luo J; Xu M
Front Cell Dev Biol; 2022; 10():919637. PubMed ID: 36531950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
